HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 231 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $34,486 | +1.0% | 903 | +50.5% | 0.00% | 0.0% |
| Q4 2022 | $34,140 | +3314.0% | 600 | +3650.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -88.9% | 16 | -95.3% | 0.00% | – |
| Q3 2020 | $9,000 | -35.7% | 339 | -58.3% | 0.00% | -100.0% |
| Q3 2019 | $14,000 | 0.0% | 812 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $14,000 | +7.7% | 812 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $13,000 | +8.3% | 812 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $12,000 | -20.0% | 812 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $15,000 | +7.1% | 812 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $14,000 | -72.5% | 812 | -68.9% | 0.00% | -75.0% |
| Q1 2018 | $51,000 | -30.1% | 2,612 | -27.7% | 0.00% | -33.3% |
| Q4 2017 | $73,000 | -27.7% | 3,612 | -37.7% | 0.01% | -50.0% |
| Q3 2017 | $101,000 | – | 5,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |